References
- Larry Norton, breast cancer committee, CALGB meeting, Chicago 6/17/06.
- Protocol document for GOG 0218.
- Kornblith AB, et al. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study. J Clin Oncol 2002;20(10):2441–2452.
- Lilenbaum RC, Herndon J, List M, Desch C, Watson D, Holland J, Weeks JC, Green MR. Single-agent (SA) versus combination chemotherapy (CC) in advanced non-small cell lung cancer (NSCLC): a CALGB randomized trial of efficacy, quality of life (Q0L), and cost-effectiveness. Proc Am Soc Clin Oncol 2002;21:la.